VIPoma risk factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2]Parminder Dhingra, M.D. [3] Homa Najafi, M.D.[4]
Overview
Overview
The most important risk factor in the development of VIPoma is a positive family history of multiple endocrine neoplasia type 1.
Risk Factors
Risk Factors
- The most important risk factor in the development of VIPoma is a positive family history of multiple endocrine neoplasia type 1.[1]
- The most cases of VIPoma are sporadic whereas in 5% of cases are associated with MEN-1.
References
References
- ↑ Perry, R R; Vinik, A I (1995). “Clinical review 72: diagnosis and management of functioning islet cell tumors”. The Journal of Clinical Endocrinology & Metabolism. 80 (8): 2273–2278. doi:10.1210/jcem.80.8.7629220. ISSN 0021-972X.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH